Terms: = Pancreatic cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Prognosis
26 results:
1. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.
Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L
ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811
[TBL] [Abstract] [Full Text] [Related]
2. Identification of key lncRNAs in the tumorigenesis of intraductal pancreatic mucinous neoplasm by coexpression network analysis.
Ding J; Li Y; Zhang Y; Fan B; Li Q; Zhang J; Zhang J
Cancer Med; 2020 Jun; 9(11):3840-3851. PubMed ID: 32239802
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of patients with invasive intraductal papillary mucinous carcinoma and invasive ductal carcinoma of the pancreas: a pathological type- and stage-matched analysis.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Matsunaga Y; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Nov; 54(11):1412-1418. PubMed ID: 31680568
[No Abstract] [Full Text] [Related]
4. Poor prognosis of common-type invasive ductal carcinomas that originate in the branching pancreatic duct.
Ando M; Shimizu Y; Sano T; Senda Y; Nimura Y; Yamao K; Nagino M; Yanagisawa A
Surg Today; 2015 Oct; 45(10):1291-8. PubMed ID: 25476465
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas.
Sugimoto M; Mitsunaga S; Yoshikawa K; Kato Y; Gotohda N; Takahashi S; Konishi M; Ikeda M; Kojima M; Ochiai A; Kaneko H
Eur J Cancer; 2014 Jul; 50(11):1900-8. PubMed ID: 24835032
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological significance of the expression of carbonic anhydrase II in human pancreatic invasive ductal cancer].
Sheng WW; Zhou JP; Kong FM; Li YJ; Dong M
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):728-31. PubMed ID: 23157907
[TBL] [Abstract] [Full Text] [Related]
7. Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer.
Nie F; Yu XL; Wang XG; Tang YF; Wang LL; Ma L
Int J Oncol; 2010 Nov; 37(5):1261-9. PubMed ID: 20878073
[TBL] [Abstract] [Full Text] [Related]
8. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
Sadakari Y; Ohuchida K; Nakata K; Ohtsuka T; Aishima S; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Surgery; 2010 Jun; 147(6):812-7. PubMed ID: 20060146
[TBL] [Abstract] [Full Text] [Related]
9. S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Fujita H; Nakata K; Ueda J; Sato N; Nagai E; Tanaka M
J Gastrointest Surg; 2009 Oct; 13(10):1852-8. PubMed ID: 19653048
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis.
Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A
Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633
[TBL] [Abstract] [Full Text] [Related]
11. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract] [Full Text] [Related]
12. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development.
Eguchi H; Ishikawa O; Ohigashi H; Tomimaru Y; Sasaki Y; Yamada T; Tsukuma H; Nakaizumi A; Imaoka S
Surgery; 2006 Jun; 139(6):749-54. PubMed ID: 16782429
[TBL] [Abstract] [Full Text] [Related]
13. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.
Saitou M; Goto M; Horinouchi M; Tamada S; Nagata K; Hamada T; Osako M; Takao S; Batra SK; Aikou T; Imai K; Yonezawa S
J Clin Pathol; 2005 Aug; 58(8):845-52. PubMed ID: 16049287
[TBL] [Abstract] [Full Text] [Related]
14. Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis.
Jinfeng M; Kimura W; Hirai I; Sakurai F; Moriya T; Mizutani M
Int J Gastrointest Cancer; 2003; 34(1):9-18. PubMed ID: 15235131
[TBL] [Abstract] [Full Text] [Related]
15. The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.
Toga T; Nio Y; Hashimoto K; Higami T; Maruyama R
Anticancer Res; 2004; 24(2C):1173-8. PubMed ID: 15154643
[TBL] [Abstract] [Full Text] [Related]
16. Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives.
Takamura M; Nio Y; Yamasawa K; Dong M; Yamaguchi K; Itakura M
Anticancer Drugs; 2002 Jan; 13(1):75-85. PubMed ID: 11914644
[TBL] [Abstract] [Full Text] [Related]
17. Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivatives.
Minari Y; Nio Y; Hirahara N; Dong M
Cancer Chemother Pharmacol; 2001 May; 47(5):415-22. PubMed ID: 11391857
[TBL] [Abstract] [Full Text] [Related]
18. Correlation between TGF-beta1 and p21 (WAF1/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas.
Hashimoto K; Nio Y; Sumi S; Toga T; Omori H; Itakura M; Yano S
Pancreas; 2001 May; 22(4):341-7. PubMed ID: 11345133
[TBL] [Abstract] [Full Text] [Related]
19. Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas.
Nio Y; Iguchi C; Yamasawa K; Sasaki S; Takamura M; Toga T; Dong M; Itakura M; Tamura K
Pancreas; 2001 Apr; 22(3):230-9. PubMed ID: 11291923
[TBL] [Abstract] [Full Text] [Related]
20. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor.
Yonezawa S; Horinouchi M; Osako M; Kubo M; Takao S; Arimura Y; Nagata K; Tanaka S; Sakoda K; Aikou T; Sato E
Pathol Int; 1999 Jan; 49(1):45-54. PubMed ID: 10227724
[TBL] [Abstract] [Full Text] [Related]
[Next]
